CLINICAL_TRIALS
trial_result
· 2017-05-11
Clinical Trial Update: Supplements for Controlling Resistance to Insulin [Phase 4]
Summary
Phase 4 trial evaluating supplements to reduce insulin resistance in obesity and type 2 diabetes mellitus was terminated; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Southern California | Conditions: Obesity, Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED | Results posted: 2017-05-11